Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234923
Status:
COMPLETED
Last Update Posted:
2008-04-03
First Post:
2005-09-13
Brief Title:
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Pilot Open-Label Randomized Comparative Study of the Antiviral Efficacy of LopinavirRitonavir Single-Drug Regimen Versus LopinavirRitonavir in Combination With LamivudineZidovudine in Antiretroviral Naïve Patients
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MONARK
Brief Summary:
The purpose of this pilot study is to obtain a preliminary assessment of the antiviral activity and tolerability of Kaletra single agent therapy as initial treatment for HIV infection relative to a Kaletra three drug standard of care reference arm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MONARK | None | None | None |
| EUDRACT 2004-816-24 | None | None | None |